These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 23595051)

  • 1. High performance of F-fluorodeoxyglucose positron emission tomography and contrast-enhanced CT in a rapid outpatient diagnostic program for patients with suspected lung cancer.
    Brocken P; van der Heijden HF; Dekhuijzen PN; Peters-Bax L; de Geus-Oei LF
    Respiration; 2014; 87(1):32-7. PubMed ID: 23595051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined 18FDG-PET and contrast enhanced CT scanning.
    Brocken P; Kiers BA; Looijen-Salamon MG; Dekhuijzen PN; Smits-van der Graaf C; Peters-Bax L; de Geus-Oei LF; van der Heijden HF
    Lung Cancer; 2012 Mar; 75(3):336-41. PubMed ID: 21943652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of (18)F-FDG PET-CT for differentiation of pulmonary pathology in an approach of outpatient fast track assessment.
    Aukema TS; Valdés Olmos RA; Klomp HM; Teertstra HJ; Belderbos JS; Vogel WV; Baas P; Burgers SA; van den Heuvel MM
    J Thorac Oncol; 2009 Oct; 4(10):1226-30. PubMed ID: 19687763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.
    Toba H; Sakiyama S; Otsuka H; Kawakami Y; Takizawa H; Kenzaki K; Kondo K; Tangoku A
    Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):859-64. PubMed ID: 22914804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
    Ohno Y; Yui M; Aoyagi K; Kishida Y; Seki S; Koyama H; Yoshikawa T
    AJR Am J Roentgenol; 2019 Feb; 212(2):311-319. PubMed ID: 30512992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is (18)F-FDG-PET/CT prognostic factor for survival in patients with small cell lung cancer? Single center experience.
    Inal A; Kucukoner M; Kaplan MA; Urakci Z; Nas N; Guven M; Dostbil Z; Altindag S; Isikdogan A
    Rev Port Pneumol; 2013; 19(6):260-5. PubMed ID: 23993406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic ability of
    Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
    Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients.
    Li S; Zhao B; Wang X; Yu J; Yan S; Lv C; Yang Y
    Clin Radiol; 2014 Aug; 69(8):e352-7. PubMed ID: 24877581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomesotheliomatous lung cancer mimicking mesothelioma on ¹⁸F-FDG PET/CT images: report of 2 cases.
    Nakamori T; Kosuda S; Kyoto Y; Fujikawa A; Naoi Y; Nakamori Y
    Jpn J Radiol; 2013 Aug; 31(8):542-5. PubMed ID: 23620108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is a selective brain (18)F-FDG PET/CT study profitable in patients with small cell lung cancer?
    Palomar Muñoz A; García Vicente AM; Bellón Guardia ME; González García B; Talavera Rubio MP; Pilkington Woll JP; Núñez García A; Poblete García VM; Cordero García JM; Soriano Castrejón A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):124-9. PubMed ID: 21722995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer.
    Pastis NJ; Greer TJ; Tanner NT; Wahlquist AE; Gordon LL; Sharma AK; Koch NC; Silvestri GA
    Chest; 2014 Aug; 146(2):406-411. PubMed ID: 24577678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size.
    Tsunezuka Y; Shimizu Y; Tanaka N; Takayanagi T; Kawano M
    World J Surg; 2007 Feb; 31(2):314-7. PubMed ID: 17219276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer patients.
    Lu Y; Xie D; Huang W; Gong H; Yu J
    Neoplasma; 2010; 57(2):129-34. PubMed ID: 20099976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.
    Berlangieri SU; Scott AM; Knight SR; Fitt GJ; Hennessy OF; Tochon-Danguy HJ; Clarke CP; McKay WJ
    Eur J Cardiothorac Surg; 1999 Sep; 16 Suppl 1():S25-30. PubMed ID: 10536941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
    Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
    Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorodeoxyglucose-positron-emission tomography/computed tomography imaging for adrenal masses in patients with lung cancer: review and diagnostic algorithm.
    Stone WZ; Wymer DC; Canales BK
    J Endourol; 2014 Jan; 28(1):104-11. PubMed ID: 23927734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up).
    Niccoli-Asabella A; Notaristefano A; Rubini D; Altini C; Ferrari C; Merenda N; Fanelli M; Rubini G
    Clin Imaging; 2013; 37(6):1098-103. PubMed ID: 23932389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.